760 related articles for article (PubMed ID: 26967246)
21. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
22. MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry.
Trabelsi S; Mama N; Ladib M; Karmeni N; Haddaji Mastouri M; Chourabi M; Mokni M; Tlili K; Krifa H; Yacoubi MT; Saad A; H'mida Ben Brahim D
Clin Transl Oncol; 2016 Apr; 18(4):391-7. PubMed ID: 26289551
[TBL] [Abstract][Full Text] [Related]
23. Targeted Bisulfite Sequencing-Based Analysis of MGMT Promoter Methylation in Meningiomas.
Bujko M; Kober P
Asian Pac J Cancer Prev; 2016; 17(5):2727-8. PubMed ID: 27268659
[No Abstract] [Full Text] [Related]
24. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).
Cabrini G; Fabbri E; Lo Nigro C; Dechecchi MC; Gambari R
Int J Oncol; 2015 Aug; 47(2):417-28. PubMed ID: 26035292
[TBL] [Abstract][Full Text] [Related]
25. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K
Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394
[TBL] [Abstract][Full Text] [Related]
26. Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms.
Schmitt AM; Pavel M; Rudolph T; Dawson H; Blank A; Komminoth P; Vassella E; Perren A
Neuroendocrinology; 2014; 100(1):35-44. PubMed ID: 25012122
[TBL] [Abstract][Full Text] [Related]
27. Gene regulation by methylation.
Mueller WC; von Deimling A
Recent Results Cancer Res; 2009; 171():217-39. PubMed ID: 19322547
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents.
Bearzatto A; Szadkowski M; Macpherson P; Jiricny J; Karran P
Cancer Res; 2000 Jun; 60(12):3262-70. PubMed ID: 10866320
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.
Binabaj MM; Bahrami A; ShahidSales S; Joodi M; Joudi Mashhad M; Hassanian SM; Anvari K; Avan A
J Cell Physiol; 2018 Jan; 233(1):378-386. PubMed ID: 28266716
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer.
Kordi-Tamandani DM; Moazeni-Roodi AK; Rigi-Ladiz MA; Hashemi M; Birjandian E; Torkamanzehi A
Arch Oral Biol; 2010 Oct; 55(10):809-14. PubMed ID: 20674887
[TBL] [Abstract][Full Text] [Related]
31. The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients.
Chen SP; Chiu SC; Wu CC; Lin SZ; Kang JC; Chen YL; Lin PC; Pang CY; Harn HJ
Genet Test Mol Biomarkers; 2009 Feb; 13(1):67-71. PubMed ID: 19309276
[TBL] [Abstract][Full Text] [Related]
32. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
Switzeny OJ; Christmann M; Renovanz M; Giese A; Sommer C; Kaina B
Clin Epigenetics; 2016; 8():49. PubMed ID: 27158275
[TBL] [Abstract][Full Text] [Related]
33. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
34. [Detection of O6-methylguanine-DNA methyltransferase promoter methylation in chemotherapy for glioma].
Zheng CQ; Ji SP; Gong F; Li AM; Tai JL; Zhang YP
Ai Zheng; 2009 Jun; 28(6):575-80. PubMed ID: 19635193
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
36. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Cancer Invest; 2010 May; 28(4):331-9. PubMed ID: 19857042
[TBL] [Abstract][Full Text] [Related]
37. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
Fumagalli C; Pruneri G; Possanzini P; Manzotti M; Barile M; Feroce I; Colleoni M; Bonanni B; Maisonneuve P; Radice P; Viale G; Barberis M
Breast Cancer Res Treat; 2012 Jul; 134(1):131-7. PubMed ID: 22228432
[TBL] [Abstract][Full Text] [Related]
38. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic implication of MGMT promoter methylation, activity and protein expression in cancer patients].
Chen Y; Qi H
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):539-42. PubMed ID: 26705056
[No Abstract] [Full Text] [Related]
40. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing.
Xie H; Tubbs R; Yang B
Int J Clin Exp Pathol; 2015; 8(1):636-42. PubMed ID: 25755756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
